"Progress in genomics since the completion of the Human Genome Project has exceeded even optimistic expectations in terms of discoveries about the genetic basis of health and disease," NHGRI Director Eric Green said in a statement. "Knowledge about the clinical relevance of genomic variants is growing in leaps and bounds, and the new and exciting challenge is to turn that knowledge into more effective healthcare."
“SolveBio helps patients by making it possible to run diagnostic applications. Genetic diagnosis involves taking a person’s DNA and comparing it to the world’s information on the relationship between DNA and health,” said Kaganovich. “We provide that reference data in a simple, easy-to-use set of APIs. It’s ‘clinical-grade’ in that it is accurate, secure, up-to-date, and versioned (you know exactly what version of a dataset you are using).”
As we enter 2020, investors, scientists and thought leaders are increasingly emphasizing the need to evolve the original concept of Femtech beyond reproductive health and what concerns the female reproductive organs, to that of a lenses through which we look into health issues that impact us differently, especially those that disproportionately affect women, such as Alzheimer’s or immunodeficiencies. The Femtech movement is progressing into a more intersectional territory, where otherwise non-female exclusive issues meet the specific needs of the female biology.
Cofactor is a large, structured listing of people, places, and things. Here you can find the description of each topic.